Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prevalence and Risk Factors for Common Diseases

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04091035
Recruitment Status : Not yet recruiting
First Posted : September 16, 2019
Last Update Posted : October 8, 2019
Sponsor:
Collaborator:
Umeå University
Information provided by (Responsible Party):
Anna Nordström, Västerbotten County Council

Brief Summary:

By using national databases in Sweden the aim of the present project is to:

  1. Investigate if the incidence of our most common diseases, such as fracture and cardiovascular disease, has changed from 1970-2017
  2. To investigate whether the risk of death for our most common diseases have changed from 1970-2017.
  3. To investigate the risk of a new episode after suffering from our most common diseases from 1970-2017
  4. To investigate the risk factors for our most common diseases, and whether these have changed from 1970.
  5. To investigate how severe disease or death affects the health of a close relative.

Condition or disease Intervention/treatment
Cardiovascular Diseases Fracture Cancer Other: To describe the incidence of disease and evaluate risk factors

Detailed Description:
Please see above on the summary.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 1000000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Prevalence and Risk Factors for Common Diseases in Sweden: A Nationwide Cohort Study
Estimated Study Start Date : November 1, 2019
Estimated Primary Completion Date : November 1, 2020
Estimated Study Completion Date : November 1, 2020

Intervention Details:
  • Other: To describe the incidence of disease and evaluate risk factors
    Se above


Primary Outcome Measures :
  1. Incidence of disease [ Time Frame: 1970-2017 ]
    To investigate the incidence of the most common diseases, and whether the incidence has changed.

  2. Age at diagnosis of disease [ Time Frame: 1970-2017 ]
    To investigate age at diagnosis of our most common diseases, and whether this has changed.

  3. Risk of death or disease in relative [ Time Frame: 1970-2017 ]
    Risk of death or disease in close relative to those diagnosed with severe disease or died.

  4. Risk factors for disease or death [ Time Frame: 1970-2017 ]
    Risk factors for our most common diseases or death


Secondary Outcome Measures :
  1. Risk for readmission [ Time Frame: 1970-2017 ]
    To investigate the risk of readmission for our most common diseases, and whether this risk has changed,



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Se above
Criteria

Inclusion Criteria:

  • All people living in Sweden that is diagnosed with our most common diseases between 1970-2017.

Exclusion Criteria:

  • None

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04091035


Contacts
Layout table for location contacts
Contact: Peter Nordström, Professor +46907851000 peter.nordstrom@umu.se
Contact: Anna Nordström anna.h.nordstrom@umu.se

Sponsors and Collaborators
Anna Nordström
Umeå University
Investigators
Layout table for investigator information
Study Director: Peter Nordström, Professor Umea University

Layout table for additonal information
Responsible Party: Anna Nordström, Associate professor, Västerbotten County Council
ClinicalTrials.gov Identifier: NCT04091035     History of Changes
Other Study ID Numbers: VasterbottenCounty
First Posted: September 16, 2019    Key Record Dates
Last Update Posted: October 8, 2019
Last Verified: September 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Cardiovascular Diseases